Comparison of once daily radiotherapy to 60 Gy and twice daily radiotherapy to 45 Gy for limited stage small-cell lung cancer

BACKGROUND: This study was designed to compare toxicities, disease control, and survival outcomes for limited disease small-cell lung cancer (LD-SCLC) treated with once daily (QD) versus twice daily (BID) radiotherapy. METHODS: All of the patients received four to six cycles of platinum plus etoposi...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Dan, Hao, Shaoyu, Tao, Cheng, Zhao, Qian, Wei, Yumei, Song, Zhengzheng, Li, Baosheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567011/
https://www.ncbi.nlm.nih.gov/pubmed/26445614
http://dx.doi.org/10.1111/1759-7714.12262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567011/
https://www.ncbi.nlm.nih.gov/pubmed/26445614
http://dx.doi.org/10.1111/1759-7714.12262

Ejemplares similares